Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V G Athyros

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Diabetes, Obesity & Metabolism|January 6, 2011
Glucagon-like peptide-1-based therapies and cardiovascular disease: looking beyond glycaemic controlP Anagnostis, V G Athyros, F Adamidou, et al.
Hippokratia|November 18, 2009
Severe exertional dyspnea as the prime manifestation of acute cytomegalovirus infection in an immunocompetent adultE D Pagourelias, A Papageorgiou, E Basayannis, et al.
Hippokratia|February 12, 2011
Paraganglioma in a young patient with asymptomatic severe hypertension: a case report and review of the literatureCh Koumaras, P Anagnostis, M Tzimou, et al.
Coronary Artery Disease|August 1, 1997
Effect of angiotensin-converting enzyme inhibitors on the power spectrum of heart rate variability in post-myocardial infarction patientsA G Kontopoulos, V G Athyros, A A Papageorgiou, et al.
Acta Cardiologica|December 8, 1998
Long-term effect of converting enzyme inhibition on circadian sympathetic and parasympathetic modulation in patients with diabetic autonomic neuropathyV G Athyros, T P Didangelos, D T Karamitsos, et al.
Current Medical Research and Opinion|March 7, 2009
Standardized arrangement for a guideline-driven treatment of the metabolic syndrome: the SAGE-METS studyV G Athyros, A Karagiannis, A I Hatzitolios, et al.
Coronary Artery Disease|November 1, 1996
Effects of simvastatin and ciprofibrate alone and in combination on lipid profile, plasma fibrinogen and low density lipoprotein particle structure and distribution in patients with familial combined hyperlipidaemia and coronary artery diseaseA G Kontopoulos, V G Athyros, A A Papageorgiou, et al.
The American Journal of Cardiology|February 1, 1996
Effect of quinapril or metoprolol on heart rate variability in post-myocardial infarction patientsA G Kontopoulos, V G Athyros, A A Papageorgiou, et al.
Clinical Drug Investigation|March 29, 2008
Effect of aldose reductase inhibition on heart rate variability in patients with severe or moderate diabetic autonomic neuropathyT P Didangelos, V G Athyros, D T Karamitsos, et al.
Atherosclerosis|July 27, 2001
Heart rate variability after long-term treatment with atorvastatin in hypercholesterolaemic patients with or without coronary artery diseaseA N Pehlivanidis, V G Athyros, D S Demitriadis, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Diabetes, Obesity & Metabolism|January 6, 2011
Glucagon-like peptide-1-based therapies and cardiovascular disease: looking beyond glycaemic controlP Anagnostis, V G Athyros, F Adamidou, et al.
Hippokratia|November 18, 2009
Severe exertional dyspnea as the prime manifestation of acute cytomegalovirus infection in an immunocompetent adultE D Pagourelias, A Papageorgiou, E Basayannis, et al.
Hippokratia|February 12, 2011
Paraganglioma in a young patient with asymptomatic severe hypertension: a case report and review of the literatureCh Koumaras, P Anagnostis, M Tzimou, et al.
Coronary Artery Disease|August 1, 1997
Effect of angiotensin-converting enzyme inhibitors on the power spectrum of heart rate variability in post-myocardial infarction patientsA G Kontopoulos, V G Athyros, A A Papageorgiou, et al.
Acta Cardiologica|December 8, 1998
Long-term effect of converting enzyme inhibition on circadian sympathetic and parasympathetic modulation in patients with diabetic autonomic neuropathyV G Athyros, T P Didangelos, D T Karamitsos, et al.
Current Medical Research and Opinion|March 7, 2009
Standardized arrangement for a guideline-driven treatment of the metabolic syndrome: the SAGE-METS studyV G Athyros, A Karagiannis, A I Hatzitolios, et al.
Coronary Artery Disease|November 1, 1996
Effects of simvastatin and ciprofibrate alone and in combination on lipid profile, plasma fibrinogen and low density lipoprotein particle structure and distribution in patients with familial combined hyperlipidaemia and coronary artery diseaseA G Kontopoulos, V G Athyros, A A Papageorgiou, et al.
The American Journal of Cardiology|February 1, 1996
Effect of quinapril or metoprolol on heart rate variability in post-myocardial infarction patientsA G Kontopoulos, V G Athyros, A A Papageorgiou, et al.
Clinical Drug Investigation|March 29, 2008
Effect of aldose reductase inhibition on heart rate variability in patients with severe or moderate diabetic autonomic neuropathyT P Didangelos, V G Athyros, D T Karamitsos, et al.
Atherosclerosis|July 27, 2001
Heart rate variability after long-term treatment with atorvastatin in hypercholesterolaemic patients with or without coronary artery diseaseA N Pehlivanidis, V G Athyros, D S Demitriadis, et al.
Pageof 6